Furthermore, it was found that DEK expression is correlated with the prognosis of a variety of human tumors such as breast cancer and ovarian cancer, is expected to become the new molecular targets of the cancer treatment.14 However, there is no study which has addressed to support increased DEK protein levels in HCC patients. The gene discussed is DEK; the disease is breast carcinoma.